Abstract
number | |
| 37 |
Lung cancer screening: A systematic review of the utilisation and effectiveness of knowledge translation interventions lung
|
| 34 |
Biomarkers for clinical outcome among patients with advanced or metastatic NSCLC treated with pembrolizumab alone or in combination with chemotherapy
Afaf Abed, Anna Reid, Nc Law, Calapre Leslie, Millward Michael, Lo Johnny, Gray Elin; DOI: 10.1111/resp.14471 |
| 41 |
Economics, equity and eligibility: Using risk models versus age-smoke history categorical criteria for selection to the international lung screening trial
Sonya Cressman, Preston Ngo, Alain Tremblay, Stephen Wade, Renee Manser, Emily Stone, Sukhinder Atkar-Khattra, Deme Karikios, Cheryl Ho, Silvia Behar Harpaz, Michael Caruana, Aleisha Fernandes, Jing Yi Weng, Annette McWilliams, Renelle Meyers, John Mayo, John Yee, Ren Yuan, Henry Marshall, Kwun Fong, Stephen Lam, Karen Canfell, Martin Tammemagi; DOI: 10.1111/resp.14471 |
| 85 |
Australians interested in the international lung screen trial of lung cancer screening and their PLCOm2012 lung cancer risk factor model prediction
|
| 60 |
Personalised risk categorisation of participants at screening entry in the international lung screen trial
Annette McWilliams, Fraser Brims, Henry Marshall, Linda Passmore, Barbara Page, Emily Stone, Renee Manser, Paul Fogarty, Sriyani Parsons, Sukhinder Atkar-Khattra, Sonya Cressman, Renelle Myers, Martin Tammemagi, Marianne Weber, Karen Canfell, Kwun Fong, Stephen Lam; DOI: 10.1111/resp.14471 |
| 66 |
Scoping the tools, materials and resources required to support the implementation of a potential national lung cancer screening program in Australia
Claire Nightingale, Alison Brown, Nicola Creagh, Lisa Whop, Katrina Anderson, Vivienne Milch, Tamsin Farrugia, Anna Boltong, Dorothy Keefe, Nicole Rankin; DOI: 10.1111/resp.14471 |
| 47 |
Discordance between clinical and pathological staging of patients with operable non-small cell lung cancer: A retrospective observational cohort study
Evangeline Samuel, Corey Thompson, Eldho Paul, Martin Cherk, Sam Ellis, Miranda Siemienowicz, Sarah Scholz, Leyou Gladys Zhang, Jasleen Grewal, Jason Cox, Christiaan Yu, Golsa Adabi, John Taverner, Julian Gooi, Stephanie Wayne, John Zalcberg, Robert Stirling; DOI: 10.1111/resp.14471 |
| 71 |
Results of 10 years of lung cancer screening in the Western Australian asbestos review program
Fraser Brims, Jessica Nash, Edward Harris, Conor Murray, Peter Franklin, Nola Olsen, Nick de Klerk; DOI: 10.1111/resp.14471 |
| 24 |
Evolution of the Victorian lung cancer registry: results of longitudinal change in outcomes measures
|
| 16 |
Physical activity levels of people at high risk for lung cancer: An observational study
Asha Bonney, Linda Lin, Jiashi Li, Siyuan Pang, Louis Irving, Daniel Steinfort, Henry Marshall, Kwun Fong, Renee Manser; DOI: 10.1111/resp.14471 |
| 49 |
Accelerating research for lung cancer: Getting the data out there
Nathan Dunn, Theresa Negrello, Danica Cossio, Gary Francois, Margot Lehman, Shoni Philpot, Jasotha Sanmugarajah, Morgan Windsor; DOI: 10.1111/resp.14471 |
| 33 |
Optimising early detection of lung cancer–Policy and advocacy learnings from other cancers
|
| 69 |
Talking telehealth in 2022–The power of the phone call
|
| 19 |
Lung cancer surgery and indigenous Australians
Frazer Kirk, Cheng He, Sumit Yadav, Wing Lo, Morgan Windsor, Christopher Cole, Rishendran Naidoo, Andrie Stroebel; DOI: 10.1111/resp.14471 |
| 36 |
Exercise and lung cancer–Which outcomes are important to patients and careers?
|
| 77 |
Smoking cessation brief intervention delivery in patients diagnosed with lung cancer: A retrospective audit
|
| 39 |
A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: The LEAPp program
Pavla Vaneckova, Michael Caruana, Preston Ngo, Silvia Behar Harpaz, Peter Sarich, Qingwei Luo, David Goldsbury, Elvin Cheng, Xue Qin Yu, Katherine Barron, Mei Ling Yap, Paul Grogan, Emily Banks, Kwung Fong, Henry Marshall, Deme Karikios, Nicole Rankin, Sonya Cressman, Martin Tammemagi, Annette McWilliams, Marianne Weber, Karen Canfell; DOI: 10.1111/resp.14471 |
| 86 |
From little things, big digital things grow: Expectations, standards and performance framework for the Australian specialist lung cancer nurse
|
| 20 |
Exploring the utilisation and effectiveness of knowledge translation and implementation science strategies by cancer registries for healthcare improvement: A systematic review and meta-analysis
|
| 25 |
Persisting gaps in optimal care of stage III non-small cell lung cancer: A Victorian patterns of care analysis
Katrina Woodford, John Reynolds, Robert Stirling, Susan Harden, Margaret Brand, Sasha Senthi; DOI: 10.1111/resp.14471 |
| 26 |
Single cell RNA sequencing reveals phenotypic predispositions to developing lung cancer in never-smokers
Venessa Chin, Jose Alquicira-Hernandez, Anne Sennabouth, Rachael McCloy, John Simes, Michael Boyer, Philip Hogg, Jane Young, Anthony Joshua, Bea Brown, Joseph Powell; DOI: 10.1111/resp.14471 |
| 48 |
Modelled costs and survival estimates for individuals with stage IV lung cancer
Preston Ngo, David Goldsbury, Stephen Wade, Brett Hughes, Zarnie Lwin, Karen Canfell, Nick Pavlakis, Marianne Weber; DOI: 10.1111/resp.14471 |
| 8 |
Tepotinib with an EGFR-tyrosine kinase inhibitor in patients with EGFR-mutant MET-amplified NSCLC: A case series
Wei-Sen Lam, Anna Eisert, Ulrike Himpe, Charlotte De Bondt, Julien Mazieres, Iacopo Petrini, Lye Mun Tho, Azura Ahmad, Yin Kwan Jeannie Chik, Wai Chung Kirsty Lee, Tsung-Ying Yang, Te-Chun Hsia, Kirti Joshi, Karin Berghoff, Soetkin Vlassak, Niki Karachaliou, Louise Young, Anthonie van der Wekken; DOI: 10.1111/resp.14471 |
| 68 |
Understanding the current therapeutic landscape for non-metastatic non-small cell lung cancer in Queensland
Margot Lehman, Pardeep Dhanda, Artika Nath, Neal Rawson, Bryan Chan, Theresa Negrello, Morgan Windsor; DOI: 10.1111/resp.14471 |
| 54 |
Clinical utility of personalised somatic genomic rearrangement biomarkers after surgical resection of non-small cell lung cancer
Boris Wong, Daniel Cameron, Ben Solomon, Tom John, Paul Mitchell, Stephen Barnett, Gavin Wright, Alex Dobrovic; DOI: 10.1111/resp.14471 |
| 94 |
In search of meaningful interactions between health practitioners and people living with lung cancer: A Vygotskian-inspired model of engagement
|
| 53 |
Key stakeholder perspectives on smoking cessation support within lung cancer screening in Australia
Nathan John Harrison, Ashleigh Sharman, Henry Marshall, Emily Stone, Joel Rhee, Mei Ling Yap, Sue OAM McCullough, Billie Bonevski, Nicole Rankin; DOI: 10.1111/resp.14471 |
| 52 |
State of origin–Comparison of selected lung cancer clinical indicators between NSW and QLD–How hard can it be?
Tracey Guan, Morgan Windsor, Margot Lehman, Jasotha Sanmugarajah, Theresa Negrello, Bin Jalaludin, Shanley Chong, Kim-Lin Chiew, Puma Sundaresan, Shalini K Vinod; DOI: 10.1111/resp.14471 |
| 43 |
Patterns of response and progression with immune-checkpoint inhibitor combinations in advanced non-small cell lung cancer
Lauren Brown, Harriet Gee, Adnan Nagrial, Eric Hau, Ines Pires Da Silva; DOI: 10.1111/resp.14471 |
| 31 |
Preliminary analysis of an ongoing phase II study of MR-guided hypofractionated adaptive radiation with concurrent chemotherapy and consolidation durvalumab for locally-advanced non-small cell lung cancer
Gregory Vlacich, Aadel Chaudhuri, Clifford Robinson, Shahed Badiyan, Carmen Bergom, Ramaswamy Govindan, Daniel Morgensztern, Siddhartha Devarakonda, Pamela Samson; DOI: 10.1111/resp.14471 |
| 62 |
Increased antigen presenting and T cell trafficking post bronchoscopic thermal ablation in non-small cell lung cancer
Kanishka Rangamuwa, Marie-Liesse Asselin-Labat, Christian Aloe, Steven Bozinovski, Michael Christie, Phillip Antippa, Daniel Steinfort; DOI: 10.1111/resp.14471 |
| 79 |
Carrying on with life as a lung cancer survivor: Qualitative insights on survivors’ employment, finances, relationships, and healthcare experiences
Rebekah Laidsaar-Powell, Bea Brown, Kimberley Mander, Jane Young, Emily Stone, Venessa Chin, Emily Banks, Nicole Rankin; DOI: 10.1111/resp.14471 |
| 72 |
Development of a peptidomimetic for the treatment of non-small cell lung cancer
|
| 74 |
Polo-like kinase-1 is a novel biomarker in resected non-small cell lung cancer treated with adjuvant platinum-based chemotherapy
Connor O'Leary, Derek Richard, Kenneth O'Byrne, Arutha Kulasinghe, Mark Adams; DOI: 10.1111/resp.14471 |
| 65 |
First 110 cases of robotic-assisted thoracic surgery in Geelong, Australia. A cohort study
|
| 45 |
Small cell lung cancer in Victoria: The association between stage-specific guideline concordant treatment and survival
Sanuki Tissera, Evangeline Samuel, Margaret Brand, Robert Stirling; DOI: 10.1111/resp.14471 |
| 23 |
A retrospective analysis of patterns of care and clinical outcomes for people diagnosed with mesothelioma in Victoria
Jessica Xue, Margaret Brand, Dani Samankula, Robert Stirling, John Zalcberg, Susan Harden; DOI: 10.1111/resp.14471 |
| 29 |
A snapshot of lung cancer in a regional Queensland hospital
|
| 44 |
Non-small cell lung cancer in Victoria: Association between stage-specific receipt of guideline-concordant treatment and survival
Sanuki Tissera, Margaret Brand, John Zalcberg, Nazmul Karim, Robert Stirling; DOI: 10.1111/resp.14471 |
| 22 |
Prevalence of incidental lung cancer detected at autopsy: A systematic review
Asha Bonney, Michelle W Ng, Michael Christie, Kwun Fong, Henry Marshall, Katharine See, Daniel Steinfort, Renee Manser; DOI: 10.1111/resp.14471 |
| 11 |
Multiomic dissection of immunotherapy response groups in lung cancer
|
| 9 |
Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
Kar Ven Cavan Chow, Brett Hughes, Kathleen Houston, Zarnie Lwin, Bryan Chan; DOI: 10.1111/resp.14471 |
| 81 |
The development of a new chapter of cancer council's national cancer prevention policy on lung cancer screening in Australia
|
| 75 |
Smoking cessation, quit attempts and smoking cessation interventions in a cohort undergoing lung cancer screening in the international lung screen trial
Samantha Kung, Ian Yang, Jaccalyne Brady, Linda Passmore, Henry Marshall; DOI: 10.1111/resp.14471 |
| 82 |
Lung cancer risk in Quitline clients
|
| 97 |
Antibiotics during systemic cancer therapy for lung cancer: Association with increased survival
Stephen Morrell, Robyn Ward, Tania Sorrell, David Roder, David Currow; DOI: 10.1111/resp.14471 |
| 98 |
The lung cancer nurse specialist: Co-designing the role with patients and careers
|
| 12 |
Concurrent right-sided bronchial-pulmonary artery fistula and left-sided basaloid squamous cell carcinoma in a patient with recurrent haemoptysis
|
| 92 |
Small RNA sequencing from EV-enriched and unenriched plasma fractions to differentiate between NSCLC with and without nodal metastasis
|
| 30 |
The incidence of rare and compound mutations of EGFR in non-small cell lung cancer and their potential clinical significance
Sharron Liang, Venessa Chin, Min Huang, Stephen Wong, Denise Riley, Ruby Luo, Wade Barrett, Tao Yang, Min Ru Qiu; DOI: 10.1111/resp.14471 |
| 21 |
Receipt of guideline-concordant treatment in lung cancer by hospital insurance status in Victoria, Australia: A population based, propensity matched observational study
Tiffany Lin, Jonathan Pham, Margaret Brand, Matthew Conron, Gavin Wright, Michelle Caldecott, Gary Richardson, Phillip Antippa, John Zalcberg, Robert Stirling; DOI: 10.1111/resp.14471 |
| 58 |
Delays to lung cancer surgery and pathological upstaging in a Western Australian tertiary centre
|
| 17 |
Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
Amelia Parker, Adriana Zingone, Brid Ryan, Wendy Cooper, Maija Kohonen-Corish, Curtis Harris, Thomas Cox; DOI: 10.1111/resp.14471 |
| 13 |
Development of an Australia and New Zealand lung cancer clinical quality registry: A protocol paper
Shantelle Smith, Lisa Briggs, Lillian Leigh, Fraser Brims, Mark Brooke, Vanessa Brunelli, Collin Chia, Paul Dawkins, Ross Lawrenson, Mary Duffy, Sue Evans, Tracy Leong, Henry Marshall, Dainik Patel, Nick Pavlakis, Jennifer Philip, Nicole Rankin, Nimit Singhal, Emily Stone, Rebecca Tay, Shalini Vinod, Morgan Windsor, Gavin Wright, David Leong, John Zalcberg, Rob Stirling; DOI: 10.1111/resp.14471 |
| 4 |
Tepotinib in patients with MET exon 14 skipping NSCLC: Analysis of all patients from VISION Cohorts A and C
Malinda Itchins, Marina Garassino, Enriqueta Felip, Hiroshi Sakai, Xiuning Le, Remi Veillon, Egbert Smit, Julien Mazieres, Alexis Cortot, Jo Raskin, Santiago Viteri, James Yang, Myung-Ju Ahn, Yi-Long Wu, Rui Ma, Jun Zhao, Aurora O'Brate, Karin Berghoff, Rolf Bruns, Gordon Otto, Paul Paik, Louise Young; DOI: 10.1111/resp.14471 |
| 90 |
Diagnostic performance of FDG-PET in screen detected lung cancers in the international lung screen trial
Annette McWilliams, Fraser Brims, Henry Marshall, Linda Passmore, Barbara Page, Emily Stone, Renee Manser, Paul Fogarty, Sukhinder Atkar-Khattra, Renelle Myers, Kwun Fong, Stephen Lam; DOI: 10.1111/resp.14471 |
| 42 |
12-month experience of a private university hospital multi-disciplinary team
|
| 88 |
Applicability of lung cancer resection specimens donated to a prospective lung bank for genomic research focus on lung cancer in never smokers
Kelly Tian Mun Chee, Edward Stephens, Maria Martins, Melanie Hollan, Barbara Page, Anita Goldsworthy, Morgan Windsor, Rishen Naidoo, Henry Marshall, Rayleen Bowman, Ian Yang, Kwun Fong; DOI: 10.1111/resp.14471 |
| 6 |
Using ex vivo bioengineered lungs to model pathologies and screening therapeutics
|
| 76 |
Addressing “near-miss” cases: Considerations for risk-based recruitment in lung cancer screening programs
Chellan Kumarasamy, Jess Nash, Peter Franklin, Nicholas de Klerk, Fraser Brims; DOI: 10.1111/resp.14471 |
| 73 |
The long haul: Ongoing COVID-19 symptoms and the needs of Australians
|
| 7 |
Surgical outcomes of lung cancer surgery in Tasmania
|
| 35 |
Role of hybrid FDG PET/contrast CT parameters at early restaging for subsequent response to immunotherapy in advanced NSCLC
|
| 64 |
Sleep quality before and after chemotherapy in lung cancer patients–A systematic review and meta-analysis
Andrew Jeklin, Robert Stirling, Jordan Maccora, RIshi Kumarahuru, Dion Paul, Afsana Afroz, Josh Wiley; DOI: 10.1111/resp.14471 |
| 57 |
Utilisation of the integrated exercise physiology and physiotherapy service at a tertiary cancer centre by people with lung cancer
|
| 38 |
Empowering peer-to-peer connection: Transitioning peer support from a nurse-led phone program to a peer-led multimodal online group–Increasing engagement
|
| 5 |
Clinical response to tepotinib according to circulating tumour DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx)
Malinda Itchins, Luis G Paz-Ares, Jan Van Meerbeeck, Santiago Viteri, Carlos Cabrera Galvez, David Vicente Baz, Young-Chul Kim, Jin-Hyoung Kang, Christopher Stroh, Dilafruz Juraeva, Rolf Bruns, Gordon Otto, Andreas Johne, Paul K. Paik, Louise Young; DOI: 10.1111/resp.14471 |
| 3 |
Dual drug piperine-paclitaxel nanoparticles inhibit migration and invasion in human breast cancer cells
|
| 32 |
Comparison of the seventh and eighth editions of AJCC TNM staging for non-small cell lung cancer: A population-based study in Queensland, Australia
Philippa Youl, Theresa Negrello, Nikkitia Golobic, Neal Rawson, Shoni Philpot, David E Theile; DOI: 10.1111/resp.14471 |
| 14 |
Activin-A, GDF-11 and TGF-beta as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer
Jennifer Lim, Stephen Wong, Adnan Nagrial, Deme Karikios, Dariush Daneshvar, Rachael McCloy, Angela Steinmann, Sandra O'Toole, Venessa Chin; DOI: 10.1111/resp.14471 |
| 83 |
Twenty years of progress; The Prince Charles hospital lung bank and its role in advancing lung cancer laboratory, clinical and molecular research
Kelly Tian Mun Chee, Maria Martins, Melanie Hollan, Deborah Courtney, Linda Passmore, Jaccalyne Brady, Elizabeth Mccaul, Edwina Duhig, Belinda Clarke, David Godbolt, Barbara Page, Morgan Davidson, Kayla Tran, John Pauli, Sheyna Manawar, Shilpi Gupta, Morgan Windsor, Rishen Naidoo, Raylee Bowman, Henry Marshall, Ian Yang, Kwun Fong; DOI: 10.1111/resp.14471 |
| 78 |
Coping and adjustment to lung cancer in the immunotherapy and targeted therapies era: Experiences of Australian lung cancer survivors
Rebekah Laidsaar-Powell, Bea Brown, Kimberley Mander, Jane Young, Emily Stone, Venessa Chin, Emily Banks, Chloe Lim, Nicole Rankin; DOI: 10.1111/resp.14471 |
| 87 |
Biomarkers for lung cancer screening–Systematic review
Jazmin Guayco, Kenneth Lopez-Loo, Henry Marshall, Ian Yang, Kwun Fong; DOI: 10.1111/resp.14471 |
| 46 |
Defining tetranucleotide repeat instability as a marker of deficient DNA repair in lung cancer
Hannah Parker, Brian GG Oliver, Alen Faiz, Veronica Cheung, Wendy A Cooper, Maija RJ Kohonen-Corish; DOI: 10.1111/resp.14471 |
| 95 |
COVID-19 impacts on lung cancer diagnosis, management and timeliness in Victoria, Australia: A population based observational study
Luc te Marvelde, Shantelle Smith, Sue Evans, John Zalcberg, Rob Stirling; DOI: 10.1111/resp.14471 |
| 18 |
Patterns of care for small cell lung cancer in Victoria, Australia: An observational cohort study
Joanna Huang, Margaret Brand, Shantelle Smith, Marliese Alexander, Matthew Conron, Mary Duffy, Thomas John, David Langton, Jacqueline Lesage, Lisa Briggs, Michael MacManus, Paul Mitchell, Inger Olesen, Phil Parente, Jennifer Philip, Evangeline Samuel, Javier Torres, Craig Underhill, John Zalcberg, Susan Harden, Rob Stirling; DOI: 10.1111/resp.14471 |
| 10 |
Retrospective cohort study mapping the clinical care pathways for advanced stage Victorian non-small cell lung cancer patients: Detecting opportunities for improved supportive and palliative care
Shantelle Smith, Anh Tran, Margaret Brand, Robert Stirling, John Zalcberg, Tennille Lewin; DOI: 10.1111/resp.14471 |
| 67 |
Stage III non-small cell lung cancer curative intent treatment: Does post code matter?
|
| 40 |
Incidence and mortality from mesothelioma 1982–2020: The Australian mesothelioma registry
Fraser Brims, Geza Benke, Justin Harvey, Tom Watson, Sue Barker, Susie Harden, Claire Cooke-Yarborough, Sonja Klebe, Karen Walker-Bone, Tim Driscoll; DOI: 10.1111/resp.14471 |
| 51 |
Feasibility and effects of a lung cancer prehabilitation exercise program
Kirsten Mooney, Dale Edgar, Chloe Goodred, Jade Flindell, Luke Bongiascia, Anna Kempton, Emily Aitken, Vinicius Cavalheri; DOI: 10.1111/resp.14471 |
| 96 |
Association of metabolic activity on FDG PET, complete pathological response and overall survival in patients with Pancoast tumours treated with trimodality therapy
Nezafati Pouya, Kal Perera, Bibhusal Thapa, Marsali Newman, Tineke Fancourt, Sze Ting Lee, Tom John, Adeline Lim, Salvatore Berlangieri, Andrew Scott, Gavin Davis, Stephen Barnett, Simon Knight; DOI: 10.1111/resp.14471 |
| 70 |
Lung cancer screening in asbestos-exposed individuals: Implications for risk-based eligibility
Jessica Nash, Edward Harris, Conor Murray, Peter Franklin, Nola Olsen, Nick de Klerk, Fraser Brims; DOI: 10.1111/resp.14471 |
| 56 |
Exploring the lung microbiome using metagenomics in an Australian cohort of people with lung cancer
Bryan Chan, Olusola Olagoke, Michael Bint, Andrew Pattison, Peter Bell, K Leigh Greathouse, Joshua Stone, Derek S Sarovich, Erin P Price; DOI: 10.1111/resp.14471 |
| 59 |
A pilot optimal pre-habilitation pathway for people with lung cancer on treatment in a regional cancer centre
|
| 27 |
Utilisation of thoracic radiotherapy for extensive stage small cell lung cancer in the era of chemoimmunotherapy: Experience from a multisite retrospective cohort study
Cassie Turner, Shannon O'Beirne, Georgena Anderson, Brett Hughes, Dinesh Vignarajah, Joanne Castelli, Zarnie Lwin, Kathleen Houston, Bryan Chan; DOI: 10.1111/resp.14471 |
| 84 |
Biomarkers of lung cancer in never-smokers: Current evidence
Edward Stephens, Kenneth Lopez-Loo, Henry Marshall, Ian Yang, Kwun Fong; DOI: 10.1111/resp.14471 |
| 28 |
Increased epithelial-mesenchymal transition changes in smokers and COPD with non-small cell lung cancer
Wenying Lu, Josie Larby, Greg Haug, Ashutosh Hardikar, Gurpreet Kaur Singhera, Tillie L Hackett, Iain Robertson, Mathew Suji Eapen, Sukhwinder Singh Sohal; DOI: 10.1111/resp.14471 |
| 63 |
Comparison of twelve lung cancer prediction scores on baseline CT scan in a lung cancer screening cohort
Paul Dawkins, Christin Coomarasamy, Linda Passmore, Barbara Page, Kwun Fong; DOI: 10.1111/resp.14471 |
| 50 |
Studying cigarette smoke extract-induced upregulation of RUNX-2 and galectin-3 in epithelial to mesenchymal transition of airway epithelial cells
|
| 50 |
Lung cancer–A silent spectre in former dust exposed workers
|
